Prenatal Depression Therapy Linked to Improved Infant Brain Development, Study Finds
New research reveals that treating maternal depression during pregnancy via talk therapy may positively influence infant brain development and emotional health.
POLICY WIRE — Denver, USA — A recent study published in the journal Nature Communications suggests that addressing depression in expectant mothers through brief talk therapy may significantly influence the neurological development of their babies before birth.
The research focuses on MOMCare, an interpersonal psychotherapy program consisting of eight 50-minute sessions designed to enhance social support, mitigate conflict, and build interpersonal skills. Researchers enrolled 234 pregnant women experiencing depressive symptoms, randomly assigning them to either the MOMCare program or a control group receiving standard mental health education and community referrals.
Previous findings from the project indicated that the intervention was highly effective, with the percentage of mothers diagnosed with depression dropping from 36% to 6% following the program. Furthermore, participants who underwent MOMCare were more likely to reach full-term pregnancies, a factor associated with improved child development and reduced hospital stays.
To assess the impact on fetal brain development, the team utilized magnetic resonance imaging (MRI) shortly after birth. The results showed that the hippocampus—a region critical for memory, learning, and emotional regulation—was 5% smaller in volume among infants whose mothers received the therapy compared to the control group.
When researchers evaluated the infants at six months, those with smaller hippocampal volumes at birth demonstrated less negative responses to unpredictable stimuli, such as a moving toy robot. While smaller brain volume is often viewed negatively in adults, the study authors suggest that in infancy, rapid brain growth may be influenced by stress, and the therapy may help regulate this developmental trajectory.
Depression affects approximately 1 in 5 women during pregnancy and is linked to increased risks of preterm birth and high blood pressure. The study authors, including Elysia Poggi Davis of the University of Denver, Benjamin L. Hankin of the University of Illinois Urbana-Champaign, and Catherine Demers of the University of Colorado Anschutz, emphasize that these findings highlight the importance of accessible mental health support for pregnant women.
While the exact biological mechanisms remain under investigation, researchers hypothesize that reducing maternal stress hormones or inflammation may play a role in these developmental changes. The team plans to continue monitoring the children to determine if these early brain changes lead to long-term benefits for mental health and well-being.
Reporting by Policy-Wire (PW)
